DAVID VEGA: Open Payments
NPI 1821608266 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 18 payments from 8 companies in 2025. Trend: 2023 $267 · 2024 $262 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $316 |
| Indivior Inc. | 2 | $62 |
| ABBVIE INC. | 2 | $54 |
| Exact Sciences Corporation | 1 | $29 |
| Novo Nordisk Inc | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Braeburn Inc. | 1 | $18 |
Products named: BREZTRI, AIRSUPRA, SUBLOCADE, UBRELVY, FARXIGA, Cologuard Collection Kit, Wegovy, JARDIANCE.
Industry payments across NV — which companies pay providers there.
